Chong Jin Oon

This inventor holds 6 USPTO granted patents. Top assignees: Government of Republic of Singapore, Government of the Republic of Singapore. Active years: 2003-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chong Jin Oon. Retrieved from https://idiyas.com/inventor/chong-jin-oon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6

Average Co-Inventor Count = 4.1

ph-index = 4

Forward Citations = 38(Granted Patents)

Company Filing History:

4 out of 4

Government of Republic of Singapore

patents

2 out of 3

Government of the Republic of Singapore

patents

Years Active: 2003-2006

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7105165 - Mutant human hepatitis B viral strain and uses thereof (2006-09-12),

2. 7038035 - Vaccine-induced hepatitis B viral strain and uses thereof (2006-05-02),

3. 7037682 - In vitro activity assay for human hepatitis B virus (HBV) DNA polymerase, and its use for screening for inhibitors of HBV DNA polymerase (2006-05-02),

4. 6787142 - Mutant human hepatitis B viral strain and uses thereof (2004-09-07),

5. 6593082 - In vitro activity assay for human hepatitis B virus (HBV) DNA polymerase, and its use for screening for inhibitors of HBV DNA polymerase (2003-07-15),

6. 6558675 - Mutant human hepatitis B viral strain and uses thereof (2003-05-06),

Title: Innovations and Contributions of Inventor Chong Jin Oon

Introduction

Chong Jin Oon is a notable inventor based in Singapore, recognized for his significant contributions to the field of virology. He holds a total of 6 patents, showcasing his innovative approach to addressing challenges in medical science, particularly concerning hepatitis B.

Latest Patents

One of his latest patents is focused on a mutant human hepatitis B viral strain and its uses. This invention provides an isolated strain of Hepatitis B virus designated Human Hepatitis B Virus Surface Antigen-'S'-133 Oon Strain, which has a specific mutation at position number 133. The invention also includes an isolated nucleic acid encoding a polypeptide that differs from the wild type hepatitis B virus. Additionally, he has developed an in vitro activity assay for human hepatitis B virus DNA polymerase, which is instrumental in screening for inhibitors of HBV DNA polymerase and testing potential anti-HBV drugs.

Career Highlights

Chong Jin Oon has worked with the Government of the Republic of Singapore, contributing his expertise to various research initiatives. His work has been pivotal in advancing the understanding and treatment of hepatitis B, a significant public health concern.

Collaborations

Throughout his career, Chong Jin Oon has collaborated with esteemed colleagues, including Gek Keow Lim and Wei Chen. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Chong Jin Oon's contributions to the field of virology through his patents and collaborations highlight his role as a leading inventor in Singapore. His work continues to impact the medical community and advance the fight against hepatitis B.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]